Biotechnology Assets Market Cap

Biotechnology Assets has a market cap or net worth of €17.01 million as of April 7, 2026. Its market cap has decreased by -21.43% in one year.

Market Cap

17.01M

Enterprise Value

18.58M

Revenue

3.05M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.23

Market Cap Chart

Since May 29, 2018, Biotechnology Assets's market cap has decreased from 74.66M to 17.01M, a decrease of -77.21%. That is a compound annual growth rate of -17.15%.

Market Cap History

Date	Market Cap	% Change
Apr 7, 2026	17.01M	19.20%
Dec 31, 2025	14.27M	-21.93%
Dec 31, 2024	18.28M	-20.03%
Dec 29, 2023	22.86M	84.02%
Dec 30, 2022	12.42M	-40.67%
Dec 30, 2021	20.94M	-3.86%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
May 29, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Grifols	5.72B
Laboratorios Farmaceuticos Rovi	4.23B
Almirall	2.65B
Pharma Mar	1.58B
Atrys Health	217.76M
Prim, S.A.	216.95M
Oryzon Genomics	216.26M
Laboratorio Reig Jofre	201.90M

Market Cap Rankings